Market Tracker

02/05 5:16pm ET

Celgene Corp (NASDAQ:CELG)

97.89
Delayed Data
As of Feb 05
 -4.04 / -3.96%
Today’s Change
92.98
Today|||52-Week Range
140.72
-18.26%
Year-to-Date

Today’s Trading

Previous close101.93
Today’s open101.72
Day’s range96.40 - 101.94
Volume7,802,324
Average volume (3 months)5,875,439
Market cap$76.9B
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+20.45%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+21.11%
P/E ratio49.1
Price/Sales10.67
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.44-1.44%
LLYEli Lilly and Co+0.04+0.05%
ABBVAbbVie-3.64-6.41%
ABTAbbott Laboratories-0.60-1.58%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateApril 21, 2016
EPS forecast (this quarter)$1.27
Annual revenue (last year)$9.3B
Annual profit (last year)$1.6B
Net profit margin17.31%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts